Initial Review Process for COVID-19 Clinical Research Protocols Seeking Approval During the Pandemic
Dear Research Community Colleagues:
Thomas Flaig, MD, Vice Chancellor for Research and John Reilly, MD, Dean of the University of Colorado School of Medicine and Vice Chancellor for Health Affairs for the University of Colorado Anschutz Medical Campus have put together a COVID-19 Coordination
and Prioritization Committee. Given limited access to the hospital, this committee will evaluate COVID-19 clinical research protocols that are seeking approval during the coronavirus outbreak.
Research Administration is providing organizational support and expertise to the committee; however, they are not the ultimate decision makers.
Committee members will vary based upon service and availability of rotating faculty from the infectious diseases, pulmonary sciences division as well as bioethics. With the current pandemic, these faculty are very aware of the changing hospital
environment. Once the COVID-19 Coordination and Prioritization Committee recommends the protocol move forward, normal regulatory review is needed and then hospital approval.
The implications being considered by this committee in evaluating inpatient COVID-19 trials include:
If you are interested in conducting COVID-19 research, complete the protocol summary template:
UCD COVID Protocol Synopsis Template 3.2020
If you have additional questions or concerns about this process contact ClinicalResearchSupportCenter@ucdenver.edu or 303-724-1111.